<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Patti MA</submitter><funding>Chemicals Management Plan at Health Canada, the Ontario Ministry of the Environment, and the Canadian Institutes for Health Research</funding><funding>NIEHS NIH HHS</funding><pagination>11332</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9517145</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(18)</volume><pubmed_abstract>Gestational arsenic exposure adversely impacts child health. Folate-mediated 1-carbon metabolism facilitates urinary excretion of arsenic and may prevent arsenic-related adverse health outcomes. We investigated the potential for maternal folate status to modify associations between gestational arsenic exposure and child health. We used data from 364 mother-child pairs in the MIREC study, a prospective pan-Canadian cohort. During pregnancy, we measured first trimester urinary arsenic concentrations, plasma folate biomarkers, and folic acid supplementation intake. At age 3 years, we evaluated twelve neurodevelopmental and anthropometric features. Using latent profile analysis and multinomial regression, we developed phenotypic profiles of child health, estimated covariate-adjusted associatio</pubmed_abstract><journal>International journal of environmental research and public health</journal><pubmed_title>Maternal Folate Status and the Relation between Gestational Arsenic Exposure and Child Health Outcomes.</pubmed_title><pmcid>PMC9517145</pmcid><funding_grant_id>R01 ES025214</funding_grant_id><funding_grant_id>R01 ES032386</funding_grant_id><funding_grant_id>R01 ES024381</funding_grant_id><funding_grant_id>MOP-81285</funding_grant_id><pubmed_authors>Papandonatos GD</pubmed_authors><pubmed_authors>Patti MA</pubmed_authors><pubmed_authors>MacFarlane AJ</pubmed_authors><pubmed_authors>Braun JM</pubmed_authors><pubmed_authors>Fisher M</pubmed_authors><pubmed_authors>Ashley-Martin J</pubmed_authors><pubmed_authors>Lanphear BP</pubmed_authors><pubmed_authors>Muckle G</pubmed_authors><pubmed_authors>Fraser WD</pubmed_authors><pubmed_authors>Kelsey KT</pubmed_authors><pubmed_authors>Arbuckle TE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Maternal Folate Status and the Relation between Gestational Arsenic Exposure and Child Health Outcomes.</name><description>Gestational arsenic exposure adversely impacts child health. Folate-mediated 1-carbon metabolism facilitates urinary excretion of arsenic and may prevent arsenic-related adverse health outcomes. We investigated the potential for maternal folate status to modify associations between gestational arsenic exposure and child health. We used data from 364 mother-child pairs in the MIREC study, a prospective pan-Canadian cohort. During pregnancy, we measured first trimester urinary arsenic concentrations, plasma folate biomarkers, and folic acid supplementation intake. At age 3 years, we evaluated twelve neurodevelopmental and anthropometric features. Using latent profile analysis and multinomial regression, we developed phenotypic profiles of child health, estimated covariate-adjusted associatio</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-19T05:16:36.034Z</modification><creation>2025-04-19T05:16:36.034Z</creation></dates><accession>S-EPMC9517145</accession><cross_references><pubmed>36141604</pubmed><doi>10.3390/ijerph191811332</doi></cross_references></HashMap>